drugset / Trial / NCT06508372

Topical Thymoquinone in Psoriasis Vulgaris

NCT06508372

Not yet recruiting 30 enrolled Assiut University
RandomizedSingle-groupTriple-blindTreatment

Summary

A previous trial found that N. sativa oil was more effective as an antipsoriatic agent, particularly when taken as both a cream and a pill. This confirmed that N. sativa possesses antipsoriatic properties and can alleviate psoriasis symptoms

Timeline

Start
2024-08-01
Primary completion
2024-12
Completion
2025-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Thymoquinone Small molecule Topical

Indications